7-84005396-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006080.3(SEMA3A):c.1303G>A(p.Val435Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0168 in 1,613,444 control chromosomes in the GnomAD database, including 284 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 15 hom., cov: 32)
Exomes 𝑓: 0.017 ( 269 hom. )
Consequence
SEMA3A
NM_006080.3 missense
NM_006080.3 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 5.95
Genes affected
SEMA3A (HGNC:10723): (semaphorin 3A) This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01249221).
BP6
Variant 7-84005396-C-T is Benign according to our data. Variant chr7-84005396-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 39716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-84005396-C-T is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0125 (1904/152192) while in subpopulation NFE AF= 0.0203 (1381/68008). AF 95% confidence interval is 0.0194. There are 15 homozygotes in gnomad4. There are 887 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1904 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3A | NM_006080.3 | c.1303G>A | p.Val435Ile | missense_variant | 11/17 | ENST00000265362.9 | NP_006071.1 | |
SEMA3A | XM_005250110.4 | c.1303G>A | p.Val435Ile | missense_variant | 14/20 | XP_005250167.1 | ||
SEMA3A | XM_047419751.1 | c.1303G>A | p.Val435Ile | missense_variant | 15/21 | XP_047275707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3A | ENST00000265362.9 | c.1303G>A | p.Val435Ile | missense_variant | 11/17 | 1 | NM_006080.3 | ENSP00000265362.3 | ||
SEMA3A | ENST00000436949.5 | c.1303G>A | p.Val435Ile | missense_variant | 12/18 | 5 | ENSP00000415260.1 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1905AN: 152074Hom.: 15 Cov.: 32
GnomAD3 genomes
AF:
AC:
1905
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0136 AC: 3428AN: 251328Hom.: 37 AF XY: 0.0142 AC XY: 1930AN XY: 135818
GnomAD3 exomes
AF:
AC:
3428
AN:
251328
Hom.:
AF XY:
AC XY:
1930
AN XY:
135818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0172 AC: 25164AN: 1461252Hom.: 269 Cov.: 30 AF XY: 0.0173 AC XY: 12566AN XY: 726976
GnomAD4 exome
AF:
AC:
25164
AN:
1461252
Hom.:
Cov.:
30
AF XY:
AC XY:
12566
AN XY:
726976
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0125 AC: 1904AN: 152192Hom.: 15 Cov.: 32 AF XY: 0.0119 AC XY: 887AN XY: 74400
GnomAD4 genome
AF:
AC:
1904
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
887
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
64
ALSPAC
AF:
AC:
72
ESP6500AA
AF:
AC:
16
ESP6500EA
AF:
AC:
120
ExAC
AF:
AC:
1671
Asia WGS
AF:
AC:
20
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3Other:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | SEMA3A: BS1, BS2 - |
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 20, 2019 | This variant is associated with the following publications: (PMID: 22927827, 29255181, 30183078, 28334861, 23643381, 25077900, 21898659, 27884173, 25839327, 24522099, 24963029) - |
Hypogonadotropic hypogonadism 16 with or without anosmia Benign:1Other:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Jul 25, 2022 | This variant is present in the Genome Aggregation Database (Highest reported MAF: 2.0% [1382/68016] including 15 total homozygotes; https://gnomad.broadinstitute.org/variant/7-84005396-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:39716). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. - |
risk factor, no assertion criteria provided | literature only | OMIM | Aug 01, 2012 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
D;D
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at